Drug
ARQ 501
ARQ 501 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
67%
Ph phase_2
2
33%
Phase Distribution
4
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
2(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 14 (66.7%)
Phase 22 (33.3%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
An Extension Study for Patients Previously Treated With ARQ 501
NCT00622063
completedphase_1
An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors
NCT00524524
completedphase_2
Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
NCT00310518
completedphase_1
ARQ 501 in Combination With Docetaxel in Patients With Cancer
NCT00099190
completedphase_2
A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
NCT00358930
Clinical Trials (6)
Showing 6 of 6 trials
NCT00622063Phase 1
An Extension Study for Patients Previously Treated With ARQ 501
NCT00524524Phase 1
An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors
NCT00310518Phase 2
Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
NCT00099190Phase 1
ARQ 501 in Combination With Docetaxel in Patients With Cancer
NCT00358930Phase 2
A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
NCT00075933Phase 1
ARQ 501 in Subjects With Cancer
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6